Rhenman & Partners Asset Management Ab Eli Lilly & CO Transaction History

Rhenman & Partners Asset Management Ab

$1.2 Billion
Q3 2024

A detailed history of Rhenman & Partners Asset Management Ab transactions in Eli Lilly & CO stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 47,500 shares of LLY stock, worth $35.8 Million. This represents 3.5% of its overall portfolio holdings.

Number of Shares

47,500

Previous 47,000 1.06%

Holding current value

$35.8 Million

Previous $42.6 Million 1.1%

% of portfolio

3.5%

Previous 4.2%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$772.14 - $960.02 $386,070 - $480,010	500 Added 1.06%	47,500 $42.1 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $5.2 Million - $6.52 Million	-7,175 Reduced 13.24%	47,000 $42.6 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $14.1 Million - $18.9 Million	-23,830 Reduced 30.55%	54,175 $42.1 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $11.6 Million - $13.6 Million	-21,995 Reduced 22.0%	78,005 $45.5 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $32.6 Million - $44.9 Million	-75,000 Reduced 42.86%	100,000 $53.7 Million
Q3 2023 Nov 09, 2023	BUY	$434.7 - $599.3 $40.9 Million - $56.3 Million	94,000 Added 116.05%	175,000 $94 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $28.4 Million - $38 Million	81,000 New	81,000 $38 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $2.89 Million - $3.37 Million	-9,000 Reduced 9.28%	88,000 $32.2 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $2.08 Million - $2.37 Million	7,000 Added 7.78%	97,000 $35.1 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $9.34 Million - $11 Million	-33,500 Reduced 27.13%	90,000 $29.2 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $10.9 Million - $13.6 Million	-46,500 Reduced 27.35%	123,500 $35.4 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $5.62 Million - $6.98 Million	25,000 Added 17.24%	170,000 $47.1 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $5.81 Million - $7.15 Million	26,200 Added 22.05%	145,000 $33.5 Million
Q2 2021 Aug 13, 2021	SELL	$180.55 - $233.54 $9.24 Million - $12 Million	-51,200 Reduced 30.12%	118,800 $27.3 Million
Q1 2021 May 14, 2021	SELL	$164.32 - $212.72 $1.64 Million - $2.13 Million	-10,000 Reduced 5.56%	170,000 $31.8 Million
Q4 2020 Jan 19, 2021	BUY	$130.46 - $172.63 $1.96 Million - $2.59 Million	15,000 Added 9.09%	180,000 $30.4 Million
Q3 2020 Oct 13, 2020	BUY	$146.22 - $169.13 $8.77 Million - $10.1 Million	60,000 Added 57.14%	165,000 $24.4 Million
Q2 2020 Jul 16, 2020	BUY	$136.42 - $164.18 $682,099 - $820,900	5,000 Added 5.0%	105,000 $17.2 Million
Q1 2020 Apr 16, 2020	SELL	$119.05 - $147.35 $1.36 Million - $1.69 Million	-11,446 Reduced 10.27%	100,000 $13.9 Million
Q4 2019 Jan 17, 2020	SELL	$106.92 - $132.43 $4.12 Million - $5.11 Million	-38,554 Reduced 25.7%	111,446 $14.6 Million
Q3 2019 Oct 16, 2019	SELL	$106.79 - $116.16 $1.07 Million - $1.16 Million	-10,000 Reduced 6.25%	150,000 $16.8 Million
Q2 2019 Jul 22, 2019	BUY	$110.79 - $129.32 $6.79 Million - $7.93 Million	61,305 Added 62.12%	160,000 $17.7 Million
Q1 2019 Apr 11, 2019	SELL	$111.31 - $131.02 $2.78 Million - $3.28 Million	-25,000 Reduced 20.21%	98,695 $12.8 Million
Q4 2018 Feb 05, 2019	SELL	$105.9 - $118.64 $4.9 Million - $5.49 Million	-46,305 Reduced 27.24%	123,695 $14.3 Million
Q3 2018 Oct 03, 2018	SELL	$85.86 - $107.31 $2.58 Million - $3.22 Million	-30,000 Reduced 15.0%	170,000 $18.2 Million
Q2 2018 Jul 20, 2018	SELL	$75.7 - $86.88 $1.73 Million - $1.99 Million	-22,859 Reduced 10.26%	200,000 $17.1 Million
Q1 2018 Apr 11, 2018	BUY	$74.21 - $87.6 $5.94 Million - $7.01 Million	80,000 Added 56.0%	222,859 $17.2 Million
Q4 2017 Jan 19, 2018	BUY	$81.94 - $87.89 $2.69 Million - $2.89 Million	32,859 Added 29.87%	142,859 $12.1 Million
Q3 2017 Oct 13, 2017	BUY	$77.07 - $85.54 $8.48 Million - $9.41 Million	110,000	110,000 $9.41 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.

Account

Rhenman & Partners Asset Management Ab Eli Lilly & CO Transaction History